(11)Commission Implementing Regulation (EU) No 1316/2014note approved the active substance Bacillus amyloliquefaciens subsp. plantarum strain D747. The Authority concludednote that as regards the dietary risk assessment for consumers some information was not available and further consideration by risk managers was required. The review report for that substancenote stated that it is not pathogenic to humans and is not expected to produce toxins that are relevant for human health. It is therefore appropriate to include that substance in Annex IV to Regulation (EC) No 396/2005.